Rephonic
Artwork for DCN Dx Expert Insights

DCN Dx Expert Insights

DCN Dx
Lateral Flow
DCN Diagnostics
IVD
Lateral Flow Assay
FDA
Generative AI
Clinical Trials
Quantitative Lateral Flow
Lateral Flow Assays
PCCP
Specimen Strategy
QMSR
Human Factors
Biodot
Biospecimens
Kinbio
Palantir
Regulatory Pathway
Intended Use
Cytiva

DCN Dx Expert Insights is a podcast for teams developing and commercializing in vitro diagnostics. Each episode brings together scientists, clinical researchers, regulatory specialists, manufacturing experts, and industry leaders to examine the decisions that determine whether an IVD program reaches the market. Topics include assay development, clinical evidence, regulatory strategy, biospecimens,... more

PublishesTwice monthlyEpisodes24Founded2 years ago
Number of ListenersCategories
Life SciencesHealth & FitnessMedicineScience

Listen to this Podcast

Artwork for DCN Dx Expert Insights

Latest Episodes

What does FDA Breakthrough Device designation mean for an in vitro diagnostic (IVD)? Learn what it takes to qualify, what evidence supports a request, and how designation can shape development and clinical study planning. In this episode of Expert In... more

After a federal court vacated FDA’s final rule for laboratory-developed tests (LDTs) in 2025, did the LDT pathway fully reopen? Not exactly. In Season 3, Episode 15 of Expert Insights, host Emily Friedland, VP of Clinical Research at DCN Dx, speaks w... more

In July 2025, FDA told WHOOP that its Blood Pressure Insights feature was an unauthorized medical device. WHOOP disputed FDA’s position and kept selling it. In January 2026, while the dispute was still open, FDA reissued its general wellness guidance... more

Why respiratory trials built on last year’s calendar are falling behind, and what sponsors need to do differently to catch the season on time. Respiratory disease patterns have stopped following the calendar sponsors are used to. Flu and RSV still sh... more

A site management CEO and a human factors specialist on what sponsors miss before a diagnostic study ever starts. Most conversations about IVD clinical research happen from the sponsor’s side of the table. This episode flips that. Emily Friedland, VP... more

Your lateral flow assay performs at the bench. Will that performance hold on the manufacturing line? Manufacturing introduces conditions the assay may not have faced at the bench. Reagent delivery must remain consistent throughout longer runs, while ... more

Many IVD clinical studies still run on a patchwork of disconnected tools: a file share here, a spreadsheet there, a separate system for clinical operations and another for the data. The handoffs between them put time, money, and clean data at risk. S... more

The 2026 IVDR transition deadlines are here, and a lot of IVD companies are sitting still. After the European Commission proposed a revision to the regulation in December 2025, many manufacturers are waiting to see what survives before they file. By ... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Recent Guests

Missy Farrell
Founder and CEO of ClinicaGenBio, a site management organization focused on non-interventional IVD studies
ClinicaGenBio
Episode: Before the Protocol: What Sponsors Miss About Sites and Human Factors
Karen Seidler
CEO and principal at Usable Solutions LLC, expert in human factors and usability for diagnostic devices
Usable Solutions LLC
Episode: Before the Protocol: What Sponsors Miss About Sites and Human Factors
John Acampado
Strategy team member, Veeva MedTech
Veeva MedTech
Episode: Off the Patchwork: What a Connected Platform Lets a CRO Do for Sponsors
Dan Simpson
Director of Regulatory Affairs at DCN Dx
DCN Dx
Episode: QMSR Is in Effect: What IVD Manufacturers Still Need to Do
Kevin Gunning
Principal Consultant at Gunning Quality Systems LLC
Gunning Quality Systems LLC
Episode: QMSR Is in Effect: What IVD Manufacturers Still Need to Do
Jim Bousshell
Senior Vice President of Biospecimens at DCN Diagnostics
DCN Diagnostics
Episode: Specimen Strategy Is Development Strategy (And Why "We'll Source It Later" Fails)
Daniel Levenson
Business Development Manager at Kinbio
Kinbio
Episode: Automation Beyond the Strip: Building Repeatable Rapid Test Production with KinBio
Pat Vaughan
DCN's Chief Operating Officer
DCN Diagnostics
Episode: Point-of-Care in 2025: Lateral Flow Grew Up. Where Will the Technology Go Next?
Charlie Mamrak
CEO of DCN Diagnostics
DCN Diagnostics
Episode: The DCN Dx Model: Integration, Scale, and What Comes Next with DCN Dx CEO Charlie Mamrak

Hosts

Emily Friedland
Host of Expert Insights
Mitzi Rettinger
Host of Expert Insights

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#4
Ukraine/Science/Life Sciences
Apple Podcasts
#43
Ukraine/Science

Top Life Sciences Podcasts

Science Friday
Science FridayScience Friday and WNYC Studios
Health Optimization Medicine Podcast
Health Optimization Medicine PodcastHealth Optimization Medicine and Practice
Science of Perception Box
Science of Perception BoxUnlikely Collaborators | Pod People
The Joy of Why
The Joy of WhySteven Strogatz, Janna Levin and Quanta Magazine
Speaking of Psychology
Speaking of PsychologyAmerican Psychological Association
The Quanta Podcast
The Quanta PodcastQuanta Magazine

Talking Points

Recent interactions between the hosts and their guests.

Before the Protocol: What Sponsors Miss About Sites and Human Factors
Q: What is the relationship between HF work and site feasibility, and what questions are often missed?
HF informs feasibility by clarifying intended users and workflows; feasibility often relies too heavily on prevalence and misses site operational realities, patient access, and enrollment pathways.
Before the Protocol: What Sponsors Miss About Sites and Human Factors
Q: Why should human factors start early in development and how does that affect the clinical trial?
HF should begin at the start of product development and inform use environments and risks; doing HF early reduces late-stage changes and de-risks the clinical study by addressing usability ahead of trials.
Before the Protocol: What Sponsors Miss About Sites and Human Factors
Q: Missy and Karen, how did you each get involved with human factors in the diagnostic space?
Karen describes a serendipitous pivot to human factors after meeting a HF professional on a plane; Missy explains entering HF via clinical research work and recognizing its importance in diagnostics.
Hype or Help? How to Evaluate Generative AI in Diagnostics with Jeremy Elser, Ph.D., Head of Science Operations at Palantir
Q: How should executives evaluate data readiness and data capture for AI-enabled diagnostics?
Prioritize complete, richly described data capture and corpus synthesis. Ensure data provenance and context are preserved so the AI can reason and be coached effectively, not just fill out templates. Focus on reducing garbage-in garbage-out risk.
Hype or Help? How to Evaluate Generative AI in Diagnostics with Jeremy Elser, Ph.D., Head of Science Operations at Palantir
Q: What makes a pitch for GenAI credible in a regulated diagnostics environment?
Look for real-world production deployments, deep-dive case studies with edge cases, and specific inputs/outputs that show how the AI integrates with the business. Avoid purely theoretical slides and demand production-level demonstrations.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About DCN Dx Expert Insights

What is DCN Dx Expert Insights about and what kind of topics does it cover?

A practical, industry-facing series focused on bringing in vitro diagnostic programs from concept to market. Episodes consistently center on hands-on topics like manufacturing scale-up, design for manufacturability, regulatory strategy, quality systems, and data-enabled platforms for diagnostics. Across conversations, guests share real-world lessons on integrating human factors, specimen strategy, site readiness, and parallel regulatory planning to avoid costly redesigns and delays. A notable pattern is the emphasis on end-to-end support for developers — from early development considerations and formative usability testing to post-market data collection and PCCPs for AI-enabled devices — underscoring a pragmatic, risk-mitigated path to mark... more

Where can I find podcast stats for DCN Dx Expert Insights?

Rephonic provides a wide range of podcast stats for DCN Dx Expert Insights. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to DCN Dx Expert Insights and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does DCN Dx Expert Insights get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for DCN Dx Expert Insights, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for DCN Dx Expert Insights?

Rephonic provides comprehensive predictive audience data for DCN Dx Expert Insights, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does DCN Dx Expert Insights have?

To see how many followers or subscribers DCN Dx Expert Insights has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

How many episodes of DCN Dx Expert Insights are there?

DCN Dx Expert Insights launched 2 years ago and published 24 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact DCN Dx Expert Insights?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for DCN Dx Expert Insights?

Rephonic pulls ratings and reviews for DCN Dx Expert Insights from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for DCN Dx Expert Insights?

Rephonic provides full transcripts for episodes of DCN Dx Expert Insights. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on DCN Dx Expert Insights?

Recent guests on DCN Dx Expert Insights include:

1. Missy Farrell
2. Karen Seidler
3. John Acampado
4. Dan Simpson
5. Kevin Gunning
6. Jim Bousshell
7. Daniel Levenson
8. Pat Vaughan

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days